Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹20 Cr
Revenue (TTM)
₹168 Cr
Net Profit (TTM)
₹3 Cr
ROE
10.5 %
ROCE
11 %
P/E Ratio
6.6
P/B Ratio
0.7
Industry P/E
35.17
EV/EBITDA
8.5
Div. Yield
0 %
Debt to Equity
1.7
Book Value
₹17.7
EPS
₹1.7
Face value
10
Shares outstanding
17,668,564
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Mono Pharmacare
| -24.3 | -11.5 | -20.7 | -50.0 | -- | -- | -- |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Mono Pharmacare
| -53.9 | -31.7 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Mono Pharmacare
|
11.5 | 20.3 | 168.3 | 3.1 | -- | 10.5 | 6.6 | 0.7 |
| 2,110.2 | 17,282.6 | 1,215.1 | 284.8 | 28.7 | 21.1 | 60.2 | 11.4 | |
| 656.2 | 12,893.6 | 7,266.8 | 627.5 | 11.9 | 12.6 | 20.5 | 2.4 | |
| 613.6 | 15,214.7 | 5,092.5 | 545.5 | 15.9 | 14.1 | 27.9 | 3.7 | |
| 839.3 | 13,375.6 | 7,918.4 | 429.9 | 10.7 | 7.2 | 30.9 | 2.0 | |
| 1,027.6 | 18,409.8 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 11.8 | 2.1 | |
| 1,404.5 | 16,092.2 | 1,419.3 | 20.1 | 8.4 | 0.5 | 800.5 | 2.8 | |
| 142.2 | 18,882.0 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.4 | |
| 391.1 | 15,752.9 | 3,720.2 | 352.1 | 13.7 | 8.2 | 44.7 | 3.3 | |
| 1,271.5 | 20,670.6 | 3,151.0 | -10.0 | 8.4 | 2.5 | 939.6 | 4.5 |
No Review & Analysis are available.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
Incorporated
2022
Chairman
--
Managing Director
Panilam Lakhatariya
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Mono Pharmacare Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Mono Pharmacare Ltd is ₹11.50 (NSE) as of 02-Apr-2026 IST. Mono Pharmacare Ltd has given a return of -50% in the last 1 years.
The P/E ratio of Mono Pharmacare Ltd is 6.58 times as on 02-Apr-2026, a 81 discount to its peers’ median range of 35.17 times.
The P/B ratio of Mono Pharmacare Ltd is 0.65 times as on 02-Apr-2026, a 80 discount to its peers’ median range of 3.21 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
13.21
|
1.31
|
|
2024
|
31.90
|
2.77
|
|
2023
|
0.00
|
0.00
|
|
2025
|
13.21
|
1.31
|
|
2024
|
31.90
|
2.77
|
The 52-week high and low of Mono Pharmacare Ltd are Rs 28.25 and Rs 9.45 as of 03-Apr-2026.
Mono Pharmacare Ltd has a market capitalisation of ₹ 20 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Mono Pharmacare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹0.35
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.